4667-61-2 Usage
Uses
Used in Chemical Synthesis:
2,2-Dimethyl-3-(Piperidin-1-Yl)Propan-1-Ol is used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Its unique chemical structure allows it to be a versatile building block for the development of various chemical products.
Used as a Solvent:
2,2-Dimethyl-3-(Piperidin-1-Yl)Propan-1-Ol is used as a solvent in various chemical processes. Its solubility in water and ability to dissolve a wide range of substances make it a valuable component in the production of different chemical formulations.
Used as a Corrosion Inhibitor:
2,2-Dimethyl-3-(Piperidin-1-Yl)Propan-1-Ol is used as a corrosion inhibitor in industrial applications. Its ability to protect metal surfaces from corrosion makes it a useful component in the maintenance and preservation of various equipment and structures.
Safety Precautions:
It is important to handle 2,2-Dimethyl-3-(Piperidin-1-Yl)Propan-1-Ol with care as it can cause irritation to the skin, eyes, and respiratory system. It should be stored and used in a well-ventilated area to minimize any potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 4667-61-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,6 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4667-61:
(6*4)+(5*6)+(4*6)+(3*7)+(2*6)+(1*1)=112
112 % 10 = 2
So 4667-61-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H21NO/c1-10(2,9-12)8-11-6-4-3-5-7-11/h12H,3-9H2,1-2H3
4667-61-2Relevant academic research and scientific papers
NOVEL TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Page/Page column 70-71, (2009/06/27)
The present invention relates to novel tricyclic derivatives having an excellent inhibitory activity on poly (ADP-ribose) polymerase, or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The tricyclic derivatives of the present invention inhibit the activity of poly (ADP-ribose) polymerase, thereby being used for the prevention or treatment of diseases that are caused by excessive activation of PARP, in particular, neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic neuropathic pain, inflammatory diseases, osteoporosis, and cancer.
